Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.191
-0.009 (-4.60%)
At close: Apr 28, 2026, 4:00 PM EDT
0.194
+0.004 (1.89%)
After-hours: Apr 28, 2026, 7:00 PM EDT
Ernexa Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
7
Market Cap
5.56M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jaguar Health | 11.51M |
| Moolec Science | 7.83M |
| CollPlant Biotechnologies | 2.37M |
| Bio Green Med Solution | 747.00K |
| PMGC Holdings | 590.08K |
| BioRestorative Therapies | 359.70K |
| Cardio Diagnostics Holdings | 14.83K |
ERNA News
- 4 weeks ago - Ernexa Therapeutics Highlights Key Catalysts as Company Advances Toward First-in-Human Clinical Trials in 2026 - GlobeNewsWire
- 2 months ago - Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series - GlobeNewsWire
- 2 months ago - Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering - GlobeNewsWire
- 3 months ago - Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA - GlobeNewsWire
- 3 months ago - Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program - GlobeNewsWire
- 4 months ago - Ernexa Therapeutics Announces Successful Pre-IND FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer - GlobeNewsWire
- 5 months ago - Ernexa Therapeutics Presents New Preclinical Data at American Society of Hematology (ASH) Annual Meeting on Lead Cell Therapy Candidate for Treatment of Ovarian Cancer - GlobeNewsWire
- 5 months ago - Ernexa Therapeutics Announces Oral Presentation at the 67th American Society of Hematology (ASH) Annual Meeting - GlobeNewsWire